Rapamycin nanoparticles improves drug bioavailability in PLAM treatment by interstitial injection

BACKGROUND: Pulmonary lymphangiomyomatosis (PLAM) is a rare interstitial lung disease characterized by diffuse cystic changes caused by the destructive proliferation of smooth muscle-like cells or LAM cells. PLAM is more common in young women than other people, and a consensus is lacking regarding P...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yahong, Jiao, Chuqiao, Lu, Xi, Nie, Yifeng, Li, Xiang, Han, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463820/
https://www.ncbi.nlm.nih.gov/pubmed/36085075
http://dx.doi.org/10.1186/s13023-022-02511-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463820/
https://www.ncbi.nlm.nih.gov/pubmed/36085075
http://dx.doi.org/10.1186/s13023-022-02511-6

Ejemplares similares